×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
CDK9 Antikörper (AA 153-372)
CDK9
Reaktivität: Human
WB, IHC, IF
Wirt: Kaninchen
Polyclonal
unconjugated
Produktnummer ABIN6138331
Produktdetails anti-CDK9 Antikörper
(ausblenden)
Target
Alle CDK9 Antikörper anzeigen
CDK9
(Cyclin-Dependent Kinase 9 (CDK9))
Bindungsspezifität
Alle Epitope für CDK9 Antikörper
AA 153-372
Reaktivität
Alle Reaktivitäten für CDK9 Antikörper
Human
Wirt
Alle Wirte für CDK9 Antikörper
Kaninchen
Klonalität
Alle Klonalitäten für CDK9 Antikörper
Polyklonal
Konjugat
Alle Konjugate für CDK9 Antikörper
Dieser CDK9 Antikörper ist unkonjugiert
Applikation
Alle Applikationen für CDK9 Antikörper
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
Sequenz
ANVLITRDGV LKLADFGLAR AFSLAKNSQP NRYTNRVVTL WYRPPELLLG ERDYGPPIDL WGAGCIMAEM WTRSPIMQGN TEQHQLALIS QLCGSITPEV WPNVDNYELY EKLELVKGQK RKVKDRLKAY VRDPYALDLI DKLLVLDPAQ RIDSDDALNH DFFWSDPMPS DLKGMLSTHL TSMFEYLAPP RRKGSQITQQ STNQSRNPAT TNQTEFERVF
Kreuzreaktivität
Human, Maus, Ratte
Produktmerkmale
Polyclonal Antibodies
Aufreinigung
Affinity purification
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 153-372 of human CDK9 (NP_001252.1).
Isotyp
IgG
Top Product
Discover our top product CDK9 Primärantikörper
Alternativen
(anzeigen)
Anwendungsinformationen
(ausblenden)
Applikationshinweise
WB,1:500 - 1:1000,IHC,1:50 - 1:200,IF,1:50 - 1:200
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Format
Liquid
Buffer
PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C. Avoid freeze / thaw cycles.
Details zu CDK9
(ausblenden)
Target
CDK9
(Cyclin-Dependent Kinase 9 (CDK9))
Andere Bezeichnung
CDK9 (CDK9 Produkte )
Synonyme
C-2k antikoerper, CDC2L4 antikoerper, CTK1 antikoerper, PITALRE antikoerper, TAK antikoerper, wu:fb22e09 antikoerper, wu:fc06c02 antikoerper, c-2k antikoerper, cdc2l4 antikoerper, cdk9 antikoerper, ctk1 antikoerper, pitalre antikoerper, tak antikoerper, CDK9 antikoerper, CG5179 antikoerper, Dmel\\CG5179 antikoerper, P-TEF antikoerper, P-TEFb antikoerper, PTefb antikoerper, cyclin dependent kinase 9 antikoerper, cyclin-dependent kinase 9 (CDC2-related kinase) antikoerper, cyclin-dependent kinase 9 L homeolog antikoerper, cyclin-dependent kinase 9 antikoerper, Cyclin-dependent kinase 9 antikoerper, cyclin-dependent kinase 9 S homeolog antikoerper, CDK9 antikoerper, cdk9 antikoerper, cdk9.L antikoerper, Cdk9 antikoerper, cdk9.S antikoerper
Hintergrund
The protein encoded by this gene is a member of the cyclin-dependent protein kinase (CDK) family. CDK family members are highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2, and known as important cell cycle regulators. This kinase was found to be a component of the multiprotein complex TAK/P-TEFb, which is an elongation factor for RNA polymerase II-directed transcription and functions by phosphorylating the C-terminal domain of the largest subunit of RNA polymerase II. This protein forms a complex with and is regulated by its regulatory subunit cyclin T or cyclin K. HIV-1 Tat protein was found to interact with this protein and cyclin T, which suggested a possible involvement of this protein in AIDS.,CDK9,C-2k,CDC2L4,CTK1,PITALRE,TAK,Epigenetics & Nuclear Signaling,Signal Transduction,Kinase,Serine/threonine kinases,Cell Biology & Developmental Biology,Cell Cycle,Immunology & Inflammation,CDK9
Molekulargewicht
42 kDa/53 kDa
Gen-ID
1025
UniProt
P50750
Pathways
Zellzyklus
Zuletzt angesehen
(ausblenden)